Thus, the killing of gemcitabine-resistant PC cells by CDF is associated with inactivation of NF-κB and COX-2 signaling pathway which is very important because these pathways are known to contributes to drug-resistance of PC cells to chemotherapeutic agents [16]–[18]. Here, NFKB1 is linked to pachyonychia congenita.